ADOCIA has expanded its strategic alliance with Tonghua Dongbao Pharmaceuticals to manufacture and supply insulin lispro and insulin glargine APIs to Adocia worldwide, excluding China. Under the Supply Agreements, Tonghua Dongbao will manufacture and supply insulin lispro and insulin glargine APIs to Adocia, in accordance with Adocia’s specifications and quality standards.   Tonghua Dongbao has an annual manufacturing capacity of more than three tons of insulin, spread over several manufacturi...